Pharsight

Aclaris patents expiration

1. Eskata patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7381427 ACLARIS Seborrheic keratosis treatment
Jun, 2022

(1 year, 9 months ago)

US10098910 ACLARIS Peroxide formulations and methods and applicators for using the same
Apr, 2035

(11 years from now)

US9980983 ACLARIS Peroxide formulations and methods and applicators for using the same
Apr, 2035

(11 years from now)

US10493103 ACLARIS Peroxide formulations and methods and applicators for using the same
Apr, 2035

(11 years from now)

US10729720 ACLARIS Peroxide formulations and methods and applicators for using the same
Apr, 2035

(11 years from now)

US9675639 ACLARIS Peroxide formulations and methods and applicators for using the same
Jul, 2035

(11 years from now)

Drugs and Companies using HYDROGEN PEROXIDE ingredient

Market Authorisation Date: 14 December, 2017

Treatment: Treatment of seborrheic keratoses that are raised

Dosage: SOLUTION;TOPICAL

More Information on Dosage

ESKATA family patents

Family Patents